The global market for Boron Neutron Capture Therapy (BNCT) was valued at USD 251 Million in the year 2024 and is projected to reach a revised size of USD 2623 Million by 2031, growing at a CAGR of ...

Boron neutron capture therapy (BNCT) is a cutting-edge cancer treatment that targets cancer cells with high precision. It involves the use of boron-containing compounds that accumulate in cancer ...

Additionally, TAE Life Sciences is evaluating the combination of BNCT with immune checkpoint inhibitors, such as anti-CTLA4, anti-PD1, and anti-PDL1, to enhance outcomes in tumors with both “hot ...

Neutron Therapeutics is a leading provider of boron neutron capture therapy (BNCT) systems for use in the radiation treatment of cancer patients. Neutron Therapeutics' flagship product, ...

Efficient boron neutron capture therapy for brain tumor with novel boron carrier. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2023 / 07 / 230713142031.htm ...

First clinical application of accelerator-based boron neutron capture therapy outside of AsiaOngoing clinical trial is enrolling patients with inoperable, locally recurrent head and neck ...

BNCT exploits the high affinity of boron-10 (10 B) atoms for low-energy neutrons. When 10 B absorbs a neutron, nuclear reactions release high-energy particles that damage the nearby biological tissue.